Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The novel bicyclic compound Wy-45,030 [1-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl cyclohexanol, hydrochloride] exhibited a neurochemical profile predictive of antidepressant activity. Like the tricyclic antidepressants, it inhibited rat brain imipramine receptor binding and synaptosomal monoamine uptake (dopamine as well as norepinephrine and serotonin). It did not inhibit monoamine oxidase. Unlike the tricyclic antidepressants, it was not antimuscarinic in the guinea pig ileum, nor did it have any appreciable affinity for brain alpha-1 adrenergic or histamine-1 binding sites. Wy-45,030 was also without affinity for alpha-2 or beta adrenergic, benzodiazepine, serotonin-1, serotonin-2, dopamine-2, and opiate receptors. Such a profile is predictive of antidepressant activity devoid of the side-effects common to tricyclic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is available both as an immediate and extended-release (XR) formulation; XR pills contain spherules in coated or encapsulated form which, when broken, release the medication rapidly (Muth et al., 1986).”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Muth et al., 1986
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
A sensitive and specific assay for the estimation of monoamine oxidase
Wurtman, R. J., & Axelrod, J. (1963) · Biochemical Pharmacology · doi:10.1016/0006-2952(63)90215-6 · Cited by 980
Neurotransmitter receptor binding
Yamamura, H. I., Enna, S. J., & Kuhar, M. J. (1978) · Raven Press eBooks · Cited by 841
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 832
Langer, S. Z., Moret, C., Raisman, R., Dubocovich, M. L., & Briley, M. (1980) · Science · doi:10.1126/science.7444441 · Cited by 376
Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortex
Möhler, H., & Okada, T. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90191-6 · Cited by 324
Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol
Fields, J. Z., Reisine, T. D., & Yamamura, H. I. (1977) · Brain Research · doi:10.1016/0006-8993(77)90084-1 · Cited by 296
Pharmacological characterization of benzodiazepine receptors in the brain
Braestrup, C., & Squires, R. F. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90085-7 · Cited by 280
Raisman, R., Briley, M. S., & Langer, S. Z. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90076-x · Cited by 249
Research works printed but not linked: 6
- Husbands, 1985, U.S. Pat. No. 4,535,186
- Savage, 1980, J. Pharmac. exp. Ther., 212, 259
- U'Prichard, 1980, 34, 385
- Yamamura, 1972, 71, 1725
- Murphy, 1983, Vol. 1, 209
- Ogren, 1983, Vol. 1, 13
Cited by
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Bymaster, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 717
“1993; Wong 1998) and venlafaxine (Muth et al. 1986; for review see Artigas 1995) with combined 5-HT and NE uptake inhibitor (SNRI) properties in a single molecule have been developed.”
BackgroundNeurotransmitter Receptor and Transporter Binding Profile of Antidepressants and Their Metabolites
Owens, M. J., Morgan, W. N., Plott, S. J., & Nemeroff, C. B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37161-7 · Cited by 676
Rowbotham, M. C., Goli, V., Kunz, N. R., & Lei, D. (2004) · Pain · doi:10.1016/j.pain.2004.05.010 · Cited by 521
“Venlafaxine does not have the anticholinergic, antihistaminergic, and a1- and a2-adrenergic-blocking side effects of tricyclics (Ananth et al., 1995; Arias et al., 1998; Muth et al., 1986) and has fewer contraindications for its use.”
BackgroundInfluential
Metadata
- Authors
- Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B.
- Corresponding author
- Muth, Eric A.
- ORCID
- Moyer, John A.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1986-12
- Volume
- 35
- Issue
- 24
- Pages
- 4493-4497
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2071765053
- Cited by
- 374
- References
- 18
- Citations by year
- 2024: 3 · 2023: 2 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 5 · 2014: 12 · 2013: 10 · 2012: 10
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- antidepressant effects, dopamine, norepinephrine, serotonin, monoamine oxidase, tricyclic antidepressants, receptor binding profiles, cyclohexanol derivatives
- MeSH terms
- Venlafaxine Hydrochloride, Animals, Antidepressive Agents, Tricyclic, Biological Assay, Brain, Cyclohexanols, Desipramine, Dopamine, Guinea Pigs, Imipramine, Monoamine Oxidase Inhibitors, Muscle Contraction, Norepinephrine, Serotonin, Synaptosomes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. https://app.cochat.ai/papers/10.1016/0006-2952(86)90769-0
- The paper
- Muth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986). Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochemical Pharmacology. https://doi.org/10.1016/0006-2952(86)90769-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.